Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $21.77M in the quarter ending March 31, 2025, a decrease of -11.17%. This brings the company's revenue in the last twelve months to $91.40M, down -14.41% year-over-year. In the year 2024, Harvard Bioscience had annual revenue of $94.14M, down -16.14%.

• Revenue (ttm): $91.40M
• Revenue Growth: -14.41%
• P/S Ratio: 0.21
• Revenue / Employee: $257,456
• Employees: 355
• Market Cap: 19.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	94.14M	-18.12M	-16.14%
Dec 31, 2023	112.25M	-1.09M	-0.96%
Dec 31, 2022	113.34M	-5.57M	-4.68%
Dec 31, 2021	118.90M	16.80M	16.46%
Dec 31, 2020	102.10M	-14.08M	-12.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.